Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Oncology - Page 16

Oncology

Stanford researchers became the first to use gene expression profiling to predict cancer outcomes
Biotechnology | Diagnostics | Non-Profit Research | Oncology

Stanford researchers became the first to use gene expression profiling to predict cancer outcomes

In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…

Read More Stanford researchers became the first to use gene expression profiling to predict cancer outcomesContinue

Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania
Disease | Life Science History | Non-Profit Research | Oncology | Therapeutics

Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania

In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…

Read More Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of PennsylvaniaContinue

The Cancer Center at Baylor College of Medicine was established
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics

The Cancer Center at Baylor College of Medicine was established

In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…

Read More The Cancer Center at Baylor College of Medicine was establishedContinue

$2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian Druker
Biotechnology | Disease | Non-Profit Research | Oncology | Therapeutics

$2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian Druker

On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…

Read More $2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian DrukerContinue

The National Cancer Institute launched the Consumer Advocates in Research and Related Activities program
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics

The National Cancer Institute launched the Consumer Advocates in Research and Related Activities program

On Sept. 10, 2001, the National Cancer Institute (NCI) launched the Consumer Advocates in Research and Related Activities…

Read More The National Cancer Institute launched the Consumer Advocates in Research and Related Activities programContinue

National Cancer Institute and ACRIN launched first multicenter study to compare digital mammography
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics | Women's Health

National Cancer Institute and ACRIN launched first multicenter study to compare digital mammography

On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…

Read More National Cancer Institute and ACRIN launched first multicenter study to compare digital mammographyContinue

The Alvin J Siteman Cancer Center was named a NCI Designated Cancer Center
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Radiology | Therapeutics

The Alvin J Siteman Cancer Center was named a NCI Designated Cancer Center

In August 2001, the Alvin J. Siteman Cancer Center was named an National Cancer Institute (NCI) -Designated Cancer…

Read More The Alvin J Siteman Cancer Center was named a NCI Designated Cancer CenterContinue

OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in women
Biotechnology | Diagnostics | Disease | Genomics | Oncology | Therapeutics | Women's Health

OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in women

On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…

Read More OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in womenContinue

The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia
Biotechnology | FDA | Non-Profit Research | Oncology | Therapeutics

The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia

On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…

Read More The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemiaContinue

Seattle Genetics completed its IPO
Biotechnology | Oncology | Therapeutics

Seattle Genetics completed its IPO

On Mar. 7, 2001, Seattle Genetics launched its IPO and sold 7 million shares at $7 per share…

Read More Seattle Genetics completed its IPOContinue

The Seattle Cancer Care Alliance opened its doors
Biotechnology | Diagnostics | Oncology | Therapeutics

The Seattle Cancer Care Alliance opened its doors

On Jan. 19, 2001, the Seattle Cancer Care Alliance outpatient clinic opened, the final phase in a more…

Read More The Seattle Cancer Care Alliance opened its doorsContinue

Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for  breast cancer detection
Biotechnology | Diagnostics | Medical Device | Oncology

Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detection

On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…

Read More Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detectionContinue

The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemia
Biotechnology | Non-Profit Research | Oncology | Therapeutics

The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemia

In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…

Read More The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemiaContinue

Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center status
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics

Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center status

In 1978, Moores Cancer Center (MCC) at UC San Diego achieved National Cancer Institute (NCI) designated comprehensive cancer…

Read More Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center statusContinue

Karmanos Institute and JP McCarthy Cord Stem Cell Bank founded
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

Karmanos Institute and JP McCarthy Cord Stem Cell Bank founded

In 2001, The J.P. McCarthy Cord Stem Cell Bank at the Karmanos Cancer Institute was founded as a…

Read More Karmanos Institute and JP McCarthy Cord Stem Cell Bank foundedContinue

The University of Minnesota Cancer Center was founded
Biotechnology | Dentistry | Non-Profit Research | Oncology | Therapeutics | Veterinary

The University of Minnesota Cancer Center was founded

In 2001, the University of Minnesota Cancer Center, now known as the Masonic Cancer Center, was founded. It…

Read More The University of Minnesota Cancer Center was foundedContinue

Holden Cancer Center awarded NCI Comprehensive Center designation
Biotechnology | Disease | Non-Profit Research | Oncology | Therapeutics

Holden Cancer Center awarded NCI Comprehensive Center designation

In 2001, the Holden Cancer Center at University of Iowa received National Cancer Institute (NCI) Comprehensive Center designation….

Read More Holden Cancer Center awarded NCI Comprehensive Center designationContinue

The Stephenson Cancer Center was established
Biotechnology | Diagnostics | Disease | NIH | Oncology | Rare Disease | Therapeutics

The Stephenson Cancer Center was established

In 2001, the Stephenson Cancer Center was established. Located on the University of Oklahoma (OU) Health Sciences Center…

Read More The Stephenson Cancer Center was establishedContinue

Vanderbilt-Ingram Cancer Center earned the NCI’s highest distinction as a Comprehensive Cancer Center
Biotechnology | Diagnostics | Oncology | Radiology | Therapeutics

Vanderbilt-Ingram Cancer Center earned the NCI’s highest distinction as a Comprehensive Cancer Center

In 2001, the Vanderbilt-Ingram Cancer Center (VICC) earned the National Cancer Institute’s (NCI) highest distinction as a Comprehensive…

Read More Vanderbilt-Ingram Cancer Center earned the NCI’s highest distinction as a Comprehensive Cancer CenterContinue

Dan and Nancy Evans awarded E. Donnall Thomas Medal of Achievement Medal
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics

Dan and Nancy Evans awarded E. Donnall Thomas Medal of Achievement Medal

In 2001, the Fred Hutchinson Business Alliance announced that the 2001 E. Donnall Thomas Medal of Achievement would…

Read More Dan and Nancy Evans awarded E. Donnall Thomas Medal of Achievement MedalContinue

President Bill Clinton signed into law the Semipostal Authorization Act
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health

President Bill Clinton signed into law the Semipostal Authorization Act

On Jul. 28, 2000, President Bill Clinton signed into law the Semipostal Authorization Act (P.L. 106-253), which gave…

Read More President Bill Clinton signed into law the Semipostal Authorization ActContinue

Holden Cancer Center awarded NCI Center designation
Biotechnology | Disease | NIH | Non-Profit Research | Oncology | Therapeutics

Holden Cancer Center awarded NCI Center designation

In 2000, the Holden Cancer Center at University of Iowa received National Cancer Institute (NCI) Center designation. The…

Read More Holden Cancer Center awarded NCI Center designationContinue

Dendreon Corporation launched its Initial Public Offering
Biotechnology | Oncology | Therapeutics

Dendreon Corporation launched its Initial Public Offering

On Jun. 16, 2000, Dendreon announced its initial public offering of 4,500,000 shares of common stock at $10.00…

Read More Dendreon Corporation launched its Initial Public OfferingContinue

The Supreme Court ruled the FDA does not have authority to regulate tobacco as a drug
Disease | FDA | Oncology | U.S. Congress

The Supreme Court ruled the FDA does not have authority to regulate tobacco as a drug

On Mar. 21, 2000, the Supreme Court ruled 5 to 4 along ideological lines, that the U.S. Food…

Read More The Supreme Court ruled the FDA does not have authority to regulate tobacco as a drugContinue

Researchers discovered that the most common form of non-Hodgkin lymphoma is actually two distinct diseases
Biotechnology | Diagnostics | Disease | Oncology

Researchers discovered that the most common form of non-Hodgkin lymphoma is actually two distinct diseases

In 2000, researchers discovered that the most common form of non-Hodgkin lymphoma (NHL), diffuse large B-cell lymphoma, is…

Read More Researchers discovered that the most common form of non-Hodgkin lymphoma is actually two distinct diseasesContinue

The  Norris Foundation committed $15 million toward construction of the Harlyne J Norris Research Tower
Biotechnology | Oncology | Radiology | Therapeutics

The Norris Foundation committed $15 million toward construction of the Harlyne J Norris Research Tower

On Jan. 10, 2012, the Norris Foundation made a $15 million commitment toward construction of the Harlyne J….

Read More The Norris Foundation committed $15 million toward construction of the Harlyne J Norris Research TowerContinue

Stanford researchers first used gene expression profiling to distinguish cancer sub-types
Biotechnology | Diagnostics | Oncology | Therapeutics

Stanford researchers first used gene expression profiling to distinguish cancer sub-types

In 2000, Stanford researchers led by Ash Alizadeh announced they had used gene expression profiling to identify two…

Read More Stanford researchers first used gene expression profiling to distinguish cancer sub-typesContinue

Georgetown Lombardi Comprehensive Cancer Center was founded
Biotechnology | Oncology | Therapeutics

Georgetown Lombardi Comprehensive Cancer Center was founded

In 2000, Georgetown Lombardi Comprehensive Cancer Center, was founded when the Georgetown University Medical Center authorized the establishment…

Read More Georgetown Lombardi Comprehensive Cancer Center was foundedContinue

The Jon M. Huntsman pledged $125 million to fund cancer research and construct the Huntsman Cancer Hospital
Biotechnology | Diagnostics | Oncology | Therapeutics

The Jon M. Huntsman pledged $125 million to fund cancer research and construct the Huntsman Cancer Hospital

On Apr. 26, 2000, the Jon M. Huntsman pledged $125 million to fund cancer research and construct the…

Read More The Jon M. Huntsman pledged $125 million to fund cancer research and construct the Huntsman Cancer HospitalContinue

H. Jon Runstad and Judith M Runstad awarded E Donnall Thomas Medal of Achievement Medal
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics

H. Jon Runstad and Judith M Runstad awarded E Donnall Thomas Medal of Achievement Medal

In 2000, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement was awarded…

Read More H. Jon Runstad and Judith M Runstad awarded E Donnall Thomas Medal of Achievement MedalContinue

Page navigation

Previous PagePrevious 1 … 14 15 16 17 18 … 28 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search